Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pfizer Inc. (PFE) had Revenue of $14.65B for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$14.65B
Net Income	$2.91B
Cost of Goods Sold	$3.78B
Gross Profit	$10.88B
Operating Expenses	$10.87B
Operating Income	$3.78B
Non-Operating Income/Expense	$-739.00M
Pre-Tax Income	$3.04B
Normalized Pre-Tax Income	$3.04B
Income after Taxes	$2.90B
Income from Continuous Operations	$2.90B
Consolidated Net Income/Loss	$2.93B
Normalized Income after Taxes	$2.90B
EBIT	$3.78B
EBITDA	$5.41B
Weighted-Average Shares Outstanding (Basic)	5.68B
Weighted-Average Shares Outstanding (Diluted)	5.71B
Earnings per Share (EPS) (Basic)	$0.51
Earnings per Share (EPS) (Diluted)	$0.51
Balance Sheet Financials
Current Assets	$43.70B
Property, Plant, and Equipment	$18.78B
Long-Term Assets	$162.39B
Total Assets	$206.09B
Current Liabilities	$37.73B
Long-Term Debt	$57.50B
Long-Term Liabilities	$79.36B
Total Liabilities	$117.08B
Common Equity	$89.01B
Tangible Shareholders Equity	$-32.69B
Shareholders Equity	$89.01B
Common Shares Outstanding	5.68B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.75B
Cash Flow from Investing Activities	$7.22B
Cash Flow from Financial Activities	$-8.42B
Beginning Cash	$1.11B
End Cash	$1.69B
Increase/Decrease in Cash	$588.00M
Stock-Based Compensation	$373.00M
Common Stock Dividends Paid	$-4.88B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.16
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.39
Debt to Equity Ratio	0.69
Gross Margin	74.22%
Operating Margin	25.82%
EBIT Margin	25.82%
EBITDA Margin	--
Pre-Tax Profit Margin	20.77%
Profit Margin	19.86%
Free Cash Flow	$571.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.07
Inventory Turnover	0.32
Receiveable Turnover	1.21
Days Sales in Receivables	74.18
Return on Equity	3.26%
Return on Tangible Equity	-8.88%
Return on Assets	1.41%
Return on Investments	1.98%
Book Value Per Share	$15.66
Free Cash Flow per Share	$0.10
Operating Cash Flow per Share	$0.31

Data from Zacks Investment Research, Inc.